Dr. Reddy’s Files Form 6-K and Publishes FY26 Earnings Call Transcript
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dr Reddy’s Laboratories ( (RDY) ) has issued an announcement.
Dr. Reddy’s Laboratories has filed a Form 6-K with the U.S. Securities and Exchange Commission in May 2026, providing an update to investors and complying with its foreign private issuer reporting obligations. The filing, signed on May 18, 2026, confirms the company’s continued adherence to disclosure requirements in the U.S. capital markets.
On May 18, 2026, the company also notified stock exchanges in India and the New York Stock Exchange that it has released the transcript of its earnings call held on May 12, 2026, covering the quarter and financial year ended March 31, 2026. The transcript has been made available on the company’s website, enhancing transparency for shareholders and analysts tracking its recent financial performance.
The most recent analyst rating on (RDY) stock is a Buy with a $16.90 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.
Spark’s Take on RDY Stock
According to Spark, TipRanks’ AI Analyst, RDY is a Neutral.
The score is driven mainly by solid but weakening fundamentals (margin/ROE compression and higher debt despite growth) and a balanced earnings-call outlook that points to FY27 margin recovery but highlights near-term profitability and working-capital risks. Technicals are neutral-to-soft and valuation support is limited given the P/E and low yield.
To see Spark’s full report on RDY stock, click here.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories is an India-based global pharmaceutical company focused on developing, manufacturing and marketing generic medicines and active pharmaceutical ingredients. The company serves regulated markets including India, the U.S. and other international geographies, and its shares are listed in India and on the New York Stock Exchange.
Average Trading Volume: 2,563,890
Technical Sentiment Signal: Hold
Current Market Cap: $11.62B
For detailed information about RDY stock, go to TipRanks’ Stock Analysis page.
